Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Serplulimab 4.5 / Nab-palitaxel 260 / Carboplatin 5, Esophageal Cancer, neoadjuvant

Protocol-ID: 3210 V1.0 (Mini), SERP4.5/NPAC260/CRBP5, Esophageal Cancer, neoadjuvant

Indication(s)

  • Esophageal Cancer; ICD-10 C15.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician.

Valid since: 13.07.2026